Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Immunocore Holdings plc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 125 | 133 | +8 |
| Shares | 36.9M | 37.5M | +569.0K (+1.5%) |
| Value | $1.92B | $2.56B | +$645.6M (+33.7%) |
New holders (23)
Institutions that held Immunocore Holdings plc at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (15)
Institutions that held Immunocore Holdings plc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| First Manhattan Co | 613,749 | $31.9M |
| Holocene Advisors, LP | 165,357 | $8.58M |
| Marshall Wace, LLP | 85,639 | $4.44M |
| Samsara BioCapital, LLC | 80,963 | $4.20M |
| ExodusPoint Capital Management, LP | 72,159 | $3.75M |
| Advisory Research Inc | 25,276 | $1.31M |
| First Trust Advisors LP | 19,826 | $1.03M |
| Campbell & CO Investment Adviser LLC | 7,965 | $413.4K |
| Graham Capital Management, L.P. | 7,914 | $410.7K |
| Aquatic Capital Management LLC | 6,500 | $337.0K |
| Squarepoint Ops LLC | 4,738 | $245.9K |
| Susquehanna International Group, LLP | 4,386 | $227.6K |
| Simplex Trading, LLC | 1,793 | $93.0K |
| Beacon Capital Management, LLC | 250 | $15.0K |
| Park Place Capital Corp | 17 | $882 |